BRPI0913347A2 - modificações estáveis de cristais de dopc - Google Patents

modificações estáveis de cristais de dopc

Info

Publication number
BRPI0913347A2
BRPI0913347A2 BRPI0913347A BRPI0913347A BRPI0913347A2 BR PI0913347 A2 BRPI0913347 A2 BR PI0913347A2 BR PI0913347 A BRPI0913347 A BR PI0913347A BR PI0913347 A BRPI0913347 A BR PI0913347A BR PI0913347 A2 BRPI0913347 A2 BR PI0913347A2
Authority
BR
Brazil
Prior art keywords
dopc
crystals
stable modifications
stable
modifications
Prior art date
Application number
BRPI0913347A
Other languages
English (en)
Inventor
Alfred Hedinger
Michael Platscher
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40227929&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI0913347(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of BRPI0913347A2 publication Critical patent/BRPI0913347A2/pt
Publication of BRPI0913347B1 publication Critical patent/BRPI0913347B1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/08—Esters of oxyacids of phosphorus
    • C07F9/09—Esters of phosphoric acids
    • C07F9/10—Phosphatides, e.g. lecithin
    • C07F9/103—Extraction or purification by physical or chemical treatment of natural phosphatides; Preparation of compositions containing phosphatides of unknown structure
    • C—CHEMISTRY; METALLURGY
    • C30—CRYSTAL GROWTH
    • C30B—SINGLE-CRYSTAL GROWTH; UNIDIRECTIONAL SOLIDIFICATION OF EUTECTIC MATERIAL OR UNIDIRECTIONAL DEMIXING OF EUTECTOID MATERIAL; REFINING BY ZONE-MELTING OF MATERIAL; PRODUCTION OF A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; SINGLE CRYSTALS OR HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; AFTER-TREATMENT OF SINGLE CRYSTALS OR A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; APPARATUS THEREFOR
    • C30B29/00—Single crystals or homogeneous polycrystalline material with defined structure characterised by the material or by their shape
    • C30B29/54—Organic compounds
    • C30B29/58—Macromolecular compounds
    • C—CHEMISTRY; METALLURGY
    • C30—CRYSTAL GROWTH
    • C30B—SINGLE-CRYSTAL GROWTH; UNIDIRECTIONAL SOLIDIFICATION OF EUTECTIC MATERIAL OR UNIDIRECTIONAL DEMIXING OF EUTECTOID MATERIAL; REFINING BY ZONE-MELTING OF MATERIAL; PRODUCTION OF A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; SINGLE CRYSTALS OR HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; AFTER-TREATMENT OF SINGLE CRYSTALS OR A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; APPARATUS THEREFOR
    • C30B7/00—Single-crystal growth from solutions using solvents which are liquid at normal temperature, e.g. aqueous solutions
    • C30B7/08—Single-crystal growth from solutions using solvents which are liquid at normal temperature, e.g. aqueous solutions by cooling of the solution

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Metallurgy (AREA)
  • Materials Engineering (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dispersion Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
BRPI0913347-0A 2008-06-06 2009-05-13 Modificações estáveis de cristais de dopc, seu uso, seu processo de preparação e suas misturas, e composição farmacêutica BRPI0913347B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP08010331.0 2008-06-06
EP08010331 2008-06-06
PCT/EP2009/003398 WO2009146779A1 (de) 2008-06-06 2009-05-13 Stabile kristallmodifikationen von dopc

Publications (2)

Publication Number Publication Date
BRPI0913347A2 true BRPI0913347A2 (pt) 2015-11-24
BRPI0913347B1 BRPI0913347B1 (pt) 2023-11-21

Family

ID=40227929

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0913347-0A BRPI0913347B1 (pt) 2008-06-06 2009-05-13 Modificações estáveis de cristais de dopc, seu uso, seu processo de preparação e suas misturas, e composição farmacêutica

Country Status (19)

Country Link
US (1) US8513446B2 (pt)
EP (1) EP2280691B1 (pt)
JP (2) JP5947541B2 (pt)
KR (2) KR101820967B1 (pt)
CN (1) CN102056592B (pt)
AU (1) AU2009254310B2 (pt)
BR (1) BRPI0913347B1 (pt)
CA (1) CA2726871C (pt)
CL (1) CL2009001370A1 (pt)
DK (1) DK2280691T3 (pt)
ES (1) ES2933098T3 (pt)
IL (1) IL209476A (pt)
MX (1) MX2010013246A (pt)
NZ (1) NZ590274A (pt)
PT (1) PT2280691T (pt)
RU (1) RU2543046C2 (pt)
TW (1) TWI458501B (pt)
WO (1) WO2009146779A1 (pt)
ZA (1) ZA201100141B (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101820967B1 (ko) * 2008-06-06 2018-01-22 메르크 파텐트 게엠베하 Ｄｏｐｃ 의 안정한 결정 변형물
WO2025084317A1 (ja) * 2023-10-16 2025-04-24 国立大学法人北海道大学 双性イオンリン脂質化合物及びそれを含む脂質ナノ粒子

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2647395C2 (de) 1976-10-20 1984-03-29 A. Nattermann & Cie GmbH, 5000 Köln Verfahren zur Herstellung von Estern des Glycerophosphocholins
RU2295954C2 (ru) * 2000-09-28 2007-03-27 Чирон Корпорейшн Микрочастицы для доставки гетерологичных нуклеиновых кислот
US7968115B2 (en) * 2004-03-05 2011-06-28 Board Of Regents, The University Of Texas System Liposomal curcumin for treatment of cancer
WO2006050327A2 (en) * 2004-10-28 2006-05-11 Alza Corporation Lyophilized liposome formulations and method
GB0803969D0 (en) * 2008-03-04 2008-04-09 Britannia Pharmaceuticals Ltd Improved phospholipid and method for its production
KR101820967B1 (ko) * 2008-06-06 2018-01-22 메르크 파텐트 게엠베하 Ｄｏｐｃ 의 안정한 결정 변형물

Also Published As

Publication number Publication date
WO2009146779A1 (de) 2009-12-10
ZA201100141B (en) 2011-10-26
JP5947541B2 (ja) 2016-07-06
KR20160047597A (ko) 2016-05-02
NZ590274A (en) 2012-07-27
EP2280691A1 (de) 2011-02-09
JP2011523951A (ja) 2011-08-25
RU2543046C2 (ru) 2015-02-27
AU2009254310B2 (en) 2014-05-22
IL209476A (en) 2016-08-31
TWI458501B (zh) 2014-11-01
CL2009001370A1 (es) 2010-06-25
CN102056592B (zh) 2013-03-27
DK2280691T3 (da) 2022-10-31
EP2280691B1 (de) 2022-08-03
CA2726871C (en) 2016-10-11
AU2009254310A1 (en) 2009-12-10
US8513446B2 (en) 2013-08-20
IL209476A0 (en) 2011-01-31
TW201012485A (en) 2010-04-01
US20110086091A1 (en) 2011-04-14
BRPI0913347B1 (pt) 2023-11-21
CN102056592A (zh) 2011-05-11
JP5972323B2 (ja) 2016-08-17
MX2010013246A (es) 2010-12-21
KR20110022660A (ko) 2011-03-07
CA2726871A1 (en) 2009-12-10
ES2933098T3 (es) 2023-02-01
RU2010154508A (ru) 2012-07-20
PT2280691T (pt) 2022-10-28
JP2015013867A (ja) 2015-01-22
KR101820967B1 (ko) 2018-01-22

Similar Documents

Publication Publication Date Title
LTPA2018008I1 (lt) Kristalai
HRP20170222T1 (hr) Kristalni oblik karbamoil-cikloheksan derivata
EP2350110A4 (en) NEW STEVIOLGLYKOSIDE
DK2262793T3 (da) Krystallinske former af nilotinib-hci
EP2124523A4 (en) BREEDING LINE P2428-5006090
BRPI0915714A2 (pt) forma cristalina de posaconazol
PT2260053E (pt) Análogos de oxitocina
BRPI0906705A2 (pt) Composto heterocíclicos
BRPI0820677A2 (pt) Misturas de compostos pesticidas
PL2493466T3 (pl) Nowe przeciwguzowe zastosowanie kabazytakselu
EP2349335A4 (en) LEVETIRACETAM IMMUNOASSAYS
FR2939193B1 (fr) Calibrage de gyroscope vibrant
FR2934751B1 (fr) Tondeuse de type autoportee
EP2110789A4 (en) PAPER MONEY PROCESSOR
EP2373326A4 (en) CRYSTALLINE FORMS OF GENISTEIN
ATE545635T1 (de) Substituierte n-oxidpyrazinderivate
SMT201600031B (it) Composti eterociclici di fenossimetile
HRP20150932T1 (xx) Heterocikliäśki spojevi
CU23884B1 (es) Derivados de dibenzotiazepina
BRPI0821567A2 (pt) Misturas de compostos pesticidas
BRPI0820650A2 (pt) Misturas de compostos pesticidas
DK2173197T3 (da) Fremgangsmåde
FR2930723B1 (fr) Orthese de cheville
EP2415774A4 (en) CRYSTALS FROM PRASUGREL HYDROBROMAT
BRPI0913347A2 (pt) modificações estáveis de cristais de dopc

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B12B Appeal against refusal [chapter 12.2 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 13/05/2009, OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF, QUE DETERMINA A ALTERACAO DO PRAZO DE CONCESSAO.